Establishment of long-term monitoring system for blood chemistry data by the national health and nutrition survey in Japan.

AIM We established a monitoring system for the annual follow-up of blood chemistry data obtained by the National Health and Nutrition Survey in Japan. METHODS Blood chemistry testing has been entrusted to SRL Inc. We used two external quality control assurance programs established by the Japan Medical Association (JMA) and by CDC/CRMLN during the previous 8-year period. Ten analytes were measured: total cholesterol, HDL cholesterol, triglycerides, urea nitrogen, uric acid, creatinine, AST (GOT), ALT (GPT), gamma-GT (gamma-GTP), and glucose. Total error (TE) was calculated from accuracy by the JMA program and precision by internal quality control of SRL. The permissible range of TE values was determined to be 50% of the evaluation limit on one side in the evaluation criteria of the College of American Pathologists (CAP). When TE fell within the permissible range, the follow-up of annual changes was considered possible. RESULTS Annual follow-up of blood chemistry data was considered possible for all the analytes except urea nitrogen. Based on this study, new permissible TE ranges are proposed. CONCLUSION We confirmed the functioning of the monitoring system for the annual follow-up of blood chemistry data obtained by the National Health and Nutrition Survey in Japan.

[1]  Shinichi Sato,et al.  Establishment of external quality control program for hs-CRP and three-year follow-up of the performance for precision and accuracy. , 2007, Journal of atherosclerosis and thrombosis.

[2]  A. Killeen,et al.  College of American Pathologists 2003 fresh frozen serum proficiency testing studies. , 2005, Archives of pathology & laboratory medicine.

[3]  Shinichi Sato,et al.  Current status of CDC lipid standardization and international needs for standardization in epidemiological studies and clinical trials in Japan. , 2004, Journal of atherosclerosis and thrombosis.

[4]  Shinichi Sato,et al.  Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. , 2003, Journal of atherosclerosis and thrombosis.

[5]  R. Jansen,et al.  The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: Guide to the Register Version 2-2003 and Procedure for Re-registration , 2003, Clinical chemistry and laboratory medicine.

[6]  T. Cole,et al.  Selection, validation, standardization, and performance of a designated comparison method for HDL-cholesterol for use in the cholesterol reference method laboratory network. , 1999, Clinical chemistry.

[7]  W. März,et al.  A New Liquid Homogeneous Assay for HDL Cholesterol Determination Evaluated in Seven Laboratories in Europe and the United States , 1999, Clinical chemistry and laboratory medicine.

[8]  J. Praestgaard,et al.  The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods. , 1998, Archives of pathology & laboratory medicine.

[9]  P. Bachorik,et al.  National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. , 1995, Clinical chemistry.

[10]  J. Eckfeldt,et al.  Accuracy verification and identification of matrix effects. The College of American Pathologists' Protocol. , 1993, Archives of pathology & laboratory medicine.

[11]  S. J. Smith,et al.  College of American Pathologists-Centers for Disease Control collaborative study for evaluating reference materials for total serum cholesterol measurements. , 1990, Archives of Pathology & Laboratory Medicine.